Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Body mass index and the risk of progression of chronic kidney disease.

Khedr A, Khedr E, House AA.

J Ren Nutr. 2011 Nov;21(6):455-61. doi: 10.1053/j.jrn.2010.12.001. Epub 2011 Mar 31.

PMID:
21454093
2.

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.

Othman M, Kawar B, El Nahas AM.

Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.

PMID:
19590231
3.

Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.

Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, Ogawa T, Uchida K, Tsuchiya K, Nitta K.

Intern Med. 2008;47(21):1859-64. Epub 2008 Nov 4.

4.

Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.

Zoppini G, Targher G, Chonchol M, Ortalda V, Negri C, Stoico V, Bonora E.

Clin J Am Soc Nephrol. 2012 Mar;7(3):401-8. doi: 10.2215/CJN.07650711. Epub 2012 Jan 26.

5.

Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.

Mohsen A, Brown R, Hoefield R, Kalra PA, O'Donoghue D, Middleton R, New D.

J Nephrol. 2012 May-Jun;25(3):384-93. doi: 10.5301/jn.5000062.

PMID:
22241634
6.

GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.

Lo JC, Go AS, Chandra M, Fan D, Kaysen GA.

Am J Kidney Dis. 2007 Oct;50(4):552-8.

PMID:
17900454
7.

Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.

Levin A, Djurdjev O, Beaulieu M, Er L.

Am J Kidney Dis. 2008 Oct;52(4):661-71. doi: 10.1053/j.ajkd.2008.06.023.

PMID:
18805347
8.

Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.

MacLaughlin HL, Cook SA, Kariyawasam D, Roseke M, van Niekerk M, Macdougall IC.

Am J Kidney Dis. 2010 Jan;55(1):69-76. doi: 10.1053/j.ajkd.2009.09.011. Epub 2009 Nov 17.

PMID:
19926371
9.

Association of body mass index with decline in residual kidney function after initiation of dialysis.

Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, Wanner C, Dekker FW; NECOSAD Study Group.

Am J Kidney Dis. 2009 Jun;53(6):1014-23. doi: 10.1053/j.ajkd.2008.11.027. Epub 2009 Feb 13.

PMID:
19217702
10.

Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.

Garland JS, Holden RM, Hopman WM, Gill SS, Nolan RL, Morton AR.

J Ren Nutr. 2013 Jan;23(1):4-11. doi: 10.1053/j.jrn.2011.12.008. Epub 2012 Apr 28.

PMID:
22542819
11.

Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects.

Brown RN, Mohsen A, Green D, Hoefield RA, Summers LK, Middleton RJ, O'Donoghue DJ, Kalra PA, New DI.

Nephrol Dial Transplant. 2012 Jul;27(7):2776-80. doi: 10.1093/ndt/gfr757. Epub 2012 Mar 22.

PMID:
22442391
12.

A study of the natural history of diabetic kidney disease (DKD).

Altemtam N, Russell J, El Nahas M.

Nephrol Dial Transplant. 2012 May;27(5):1847-54. doi: 10.1093/ndt/gfr561. Epub 2011 Nov 5.

PMID:
22058177
13.

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL.

Arch Intern Med. 2005 Apr 25;165(8):947-53.

PMID:
15851648
14.

Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.

Jones C, Roderick P, Harris S, Rogerson M.

Nephrol Dial Transplant. 2006 Aug;21(8):2133-43. Epub 2006 Apr 27.

PMID:
16644779
15.

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.

Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.

Am J Kidney Dis. 2009 Apr;53(4):606-16. doi: 10.1053/j.ajkd.2008.11.026. Epub 2009 Feb 12.

PMID:
19216016
16.

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.

Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezène F, Berthoux F.

Am J Kidney Dis. 2001 Apr;37(4):720-7.

PMID:
11273871
17.

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.

Munkhaugen J, Lydersen S, Widerøe TE, Hallan S.

Am J Kidney Dis. 2009 Oct;54(4):638-46. doi: 10.1053/j.ajkd.2009.03.023. Epub 2009 Jun 10.

PMID:
19515474
19.

Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients.

Armstrong KA, Campbell SB, Hawley CM, Nicol DL, Johnson DW, Isbel NM.

Am J Transplant. 2005 Nov;5(11):2710-8.

20.

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL.

Ann Intern Med. 1995 Nov 15;123(10):754-62.

PMID:
7574193

Supplemental Content

Support Center